US FDA commissioner Makary resigns amid chaos and questions
By 
Rebecca Trager2026-05-14T14:13:00
Marty Makary’s departure, amid reports that Trump planned to fire him, is the result of an ‘inherited crisis’ and ‘shifting FDA standards’, BIO says
The official departure of the embattled US Food and Drug Administration (FDA) commissioner Marty Makary on 12 May, following public tension between him and the Trump administration, is the latest high-profile shake-up at the agency since Donald Trump returned as US president last year. The Biotechnology Innovation Organization (BIO), which primarily represents the biotech sector in the US, blamed Makary’s resignation – which was foreshadowed by media reports that the President intended to fire him – on ongoing turmoil at the agency.